A password will be e-mailed to you.

Kratom Could Help Fight Opiate Addiction And Withdrawal – Kratomaton Biweekly Update 16/07/2018

We’re back in action!
 

Hello and welcome to the Kratomaton Biweekly update for July 16th, 2018!

This week, some promising kratom research has surfaced, United States Congress has delayed pending kratom legislation, and of course, we have some sweet kratom discounts for you and yours!  
📰 KRATOM IN THE NEWS
 

New Kratom Study Finds That Mitragynine May Be Valuable In Combating Opiate Addiction And Withdrawal

Last month, a group of researchers made stunning new conclusions that could very well challenge some existing public perceptions of kratom. The authors of the paper, entitled “Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7‐hydroxymitragynine,” found that one of kratom’s primary psychoactive alkaloids, mitragynine, could, in fact, have therapeutic value in combating opiate addiction and withdrawal. According to the authors, mitragynine “does not have abuse potential and reduces morphine intake” – ostensibly making it an effective treatment option for those suffering at the hands of addictive opiate drugs like morphine. Unfortunately, these medicinal applications don’t seem to apply to another primary kratom alkaloid, called 7-hydroxymitragynine (or 7-HMG for short). The researchers concluded that, unlike mitragynine, 7-HMG has a “high abuse potential” and “may also increase the intake of other opiates,” given the response it generated with rats during animal trials. However, it may be necessary to take these findings with a grain of salt, given that 7-HMG only accounts for 2% of kratom’s alkaloid content, while mitragynine represents a whopping 66% .

United States Legislation Involving Kratom Delayed

A final verdict on a large grouping of 57 or more bills intended to crack down on the opioid crisis within the United States – including the notorious SITSA – has been delayed. Writing on behalf of the American Kratom Association, Public Policy Expert Mac Haddow stated that “Republican Senate Majority Leader Mitch McConnell will likely wait until November to consider any of these opioid bills.” In light of this news, many American kratom users with concerns regarding the plant’s tentative legality will likely be able to put their fears on-hold. That said, American kratom advocates shouldn’t rest on their laurels, either! Facing mounting pressures from various US institutions including the FDA, kratom’s legality remains hotly contested. To keep up with US legislation involving kratom, be sure to click here and visit often!  
💲 DISCOUNTS AND SALES
 

 Phytoextractum

  • 15% off any order with code “HOT15
  • 20% off orders over $250 with code “HOT20
  • Get FREE overnight shipping with code “SHIPJULY

 Canada Kratom Express

  • Save 15% on any Bali strains with code “bali15.” Code not valid for Custom Packs or Custom Split Kilos.

Check out our dedicated deals and discounts page here, and be sure to follow us on twitter for minute-to-minute updates on kratom sales!

 
🔥 VENDOR UPDATES

New Vendors

No new vendors were added since the last update! If we’re totally slacking and missed one, let us know!  
🌿 STRAIN UPDATES

New Strains

No new strains were added since the last update! If we’re totally slacking and missed one, let us know!  
❤ DONATE

If you’d like to make a contribution to Kratomaton in the form of a donation, you can now do so here via PayPal or cryptocurrency. We appreciate your generosity!
👍 SUBSCRIBE
  Want to stay in the loop? Subscribe to our weekly newsletter and get regular updates on the latest kratom news, discounts, and more. It’s free and perhaps, more importantly, 100% spam-free!

Click here to subscribe to our newsletter!

 
That’s it for this week’s update – thanks for stopping by, and all the best to you and yours! Love, Kratomaton

Works Cited

Hassan, Z., Muzaimi, M., Navaratnam, V., H.M. Yusoff, N., W. Suhaimi, F., Vadivelu, R., … P. Müller, C. (2013). From Kratom to mitragynine and its derivatives: Physiological and behavioural effects related to use, abuse, and addiction (Vol. 37). https://doi.org/10.1016/j.neubiorev.2012.11.012